Special Issue "Medication Use in Pediatrics"

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: closed (31 August 2019).

Special Issue Editors

Prof. Dr. Sandra Benavides
Website
Guest Editor
Department of Administrative and Clinical Sciences, College of Pharmacy, Larkin Health Sciences Institute, 18301 North Miami Avenue, Suite 1, Miami, FL 33169, USA
Interests: obesity; diabetes; ambulatory care services
Special Issues and Collections in MDPI journals
Prof. Dr. Shirin Madzhidova

Guest Editor
PCOM Georgia School of Pharmacy, Suwanee, GA 30024, USA
Interests: complementary and alternative medicine, pediatric nutrition, asthma, sickle cell

Special Issue Information

Dear Colleagues,

In pediatric pharmacotherapy, clinicians are often left to use case reports, case series, and retrospective reviews to determine the most efficacious and safe pharmacotherapy in pediatric patients. Despite federal legistlation, the lag time for pediatric-specific labeling for drugs approved for use in adults is approximately eight years. This lag time necessitates the use of medications off-lable. The intent of this Special Issue is to provide clinicians with data supporting or cautioning use of medications that may have limited data to optimize efficacious and safe pharmacotherapy in pediatrics.


We invite authors to share expeiences with medications in pediatric patients with limited data related to efficacy and safety. This may include experience with new dosing regimens, monitoring parameters, and pharmacokinetic or pharmacogenomic considerations. Our hope is that this Issue can contribute to and advance pediatric pharmacotherapy.

Prof. Dr. Sandra Benavides
Prof. Dr. Shirin Madzhidova
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Pharmacotherapy
  • Monitoring
  • Pharmacogenomics
  • Off-label
  • Pediatric

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

Open AccessConference Report
Minimizing Medication Errors from Electronic Prescription Transmission—Digitizing Compounded Drug Preparations
Pharmacy 2019, 7(4), 149; https://doi.org/10.3390/pharmacy7040149 - 07 Nov 2019
Abstract
Lack of standardization related to compounded drug preparations, especially in the transition of care situations, threatens patient safety by facilitating medication error. This paper outlines progress to-date from the United States Pharmacopeia (USP) Expert Panel on the Exchange of Compounded Drug Preparation Information [...] Read more.
Lack of standardization related to compounded drug preparations, especially in the transition of care situations, threatens patient safety by facilitating medication error. This paper outlines progress to-date from the United States Pharmacopeia (USP) Expert Panel on the Exchange of Compounded Drug Preparation Information in Health IT Systems. The work plan developed for the group is focused on proposing a set of encoding rules that would govern how compounded nonsterile drug preparations (CNSPs) are digitized and exchanged, including patient electronic health records (EHR), pharmacy systems, e-prescribing (eRx), and other Health IT (HIT) systems to ensure a seamless compounding process tailored to the needs of an individual patient. Included in this work are identifying authorized compounding monographs, surveying provider and end-user groups for information about data specificity during e-prescribing, and generating guidelines for the development of a compatible data model for clinical formulation identifiers (CF-IDs). This paper will also discuss how evolving nomenclature standards for CNSPs within HIT systems are part of a quality assurance system for comprehensive medication management (CMM) in children, thereby minimizing medication errors across the continuum of care. Finally, a network approach for the design of medication management systems for children and their families/caregivers is proposed. Full article
(This article belongs to the Special Issue Medication Use in Pediatrics)
Back to TopTop